1. Histone Demethylase KDM7A Regulates Androgen Receptor Activity, and Its Chemical Inhibitor TC-E 5002 Overcomes Cisplatin-Resistance in Bladder Cancer Cells
   Kyoung-Hwa Lee et al, 2020, International Journal of Molecular Sciences CrossRef
2. Current Systemic Treatment Options in Metastatic Urothelial Carcinoma after Progression on Checkpoint Inhibition Therapy—A Systemic Review Combined with Single-Group Meta-Analysis of Three Studies Testing Enfortumab Vedotin
   Susanne Deininger et al, 2021, Cancers CrossRef
3. Prognostic value of prostate volume in non-muscle invasive bladder cancer
   Won Sik Ham et al, 2021, Scientific Reports CrossRef
4. Inhibition of Androgen Signalling Improves the Outcomes of Therapies for Bladder Cancer: Results from a Systematic Review of Preclinical and Clinical Evidence and Meta-Analysis of Clinical Studies
   Massimiliano Creta et al, 2021, Diagnostics CrossRef
5. Are androgen receptor agonists a treatment option in bladder cancer?
   Michael L. De Ieso et al, 2025, The Journal of Steroid Biochemistry and Molecular Biology CrossRef
6. Immunohistochemical expression of androgen receptors in urothelial carcinoma of urinary bladder. Is it significant? Experience from coastal India
   Disha Jindal et al, 2023, Archivio Italiano di Urologia e Andrologia CrossRef
7. The Role of Androgens and Androgen Receptor in Human Bladder Cancer
   Elizabeth Martínez-Rojo et al, 2021, Biomolecules CrossRef
8. Androgen deprivation therapy for prostate cancer and the risk of bladder cancer: A systematic review of observational studies
   Christina Santella et al, 2020, Urologic Oncology: Seminars and Original Investigations CrossRef
9. Androgen receptor and immune cell PD-L1 expression in bladder tumors predicts disease recurrence and survival
   Paul Toren et al, 2021, World Journal of Urology CrossRef